Data protection
EU data protection guidance on Covid-19 apps

23 April 2020 - Posted by: Nieke Vanavermaete
On 16 April 2020, the European Commission issued a Guidance on Apps supporting the fight against COVID 19 pandemic in relation to data protection (the Guidance). The aim is to set out requirements which apps should meet to ensure compliance with EU privacy legislation, in particular the GDPR and the ePrivacy Directive. The Guidance is › Read More
EU: On the Origin of Big Data is D.A.R.W.I.N the future?

04 February 2020 - Posted by: Benjamin Scrace
A joint task force of the European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) has proposed a new approach to the use of “big data” in EU medicines regulation. The report, from the Big Data Task Force (BDTF) (accessed here), contributes to the EMA and HMA’s “EU Network Strategy” to 2025 and shows › Read More

01 July 2019 - Posted by: Laurie-Anne Ancenys
On 29 May 2019, the French National Ethical Consultative Committee for Life Sciences and Health (CCNE) delivered its Opinion (n°130) on ethical issues in connection with big data in the health sector (the Opinion). The Opinion aims at identifying the ethical challenges raised by the exploitation of large set of data in healthcare and provide › Read More
AI in health: the launch of the French Health Data Hub

20 May 2019 - Posted by: Laurie-Anne Ancenys
The French Office parlementaire d’évaluation des choix scientifiques (the Office) has published a report on artificial intelligence and health data following the public hearing organised in February 2019, in the form of two round tables on artificial intelligence and health data. The hearing, attended by AI researchers, entrepreneurs, public and private stakeholders of the health › Read More
15 February 2019 - Posted by: Emma Keeling
On 23 January 2019, the European Data Protection Board (the EDPB) adopted an opinion on the interplay between the EU Clinical Trials Regulation (536/2014) (the CTR) and the General Data Protection Regulation (2016/679) (the GDPR) (the Opinion). The Opinion aims to provide greater certainty for those conducting clinical trials, clarifying: the distinction between consent requirements › Read More